Document is current
Any future updates will be listed below
-
Authors
Caramelli, Bruno http://orcid.org/0000-0001-6718-8456
Yu, Pai Ching
Cardozo, Francisco A. M.
Magalhães, Iuri R.
Spera, Raphael R.
Amado, Daniel K.
Escalante-Rojas, Maria C.
Gualandro, Danielle M.
Calderaro, Daniela
Tavares, Caio A. M.
Borges-Junior, Flavio A.
Pastana, Adriana F.
Matheus, Mariana G.
Brucki, Sonia M. D.
Rodrigues, Ana Carolina O.
Nitrini, Ricardo
Caramelli, Paulo
-
Funding
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (309454/2020-4, 308171/2017-9)
- License Information
-
More Information
Article History
Received: 9 April 2022
Accepted: 12 September 2022
First Online: 26 October 2022
Declarations
:
: GIRAF study was approved by the local ethics committee (CAAE 30573614.3.1001.0068) and complies with ethics principles from the Declaration of Helsinki and International Conference on Harmonization Good Clinical. All eligible patients provided informed consent to be included in the study.
: Not applicable.
: BC received consulting fee from Bayer, SERVIER, and Elsevier; DKA and RRS performed the neuropsychological tests through a grant from Boehringer Ingelheim do Brasil; PCY perfomed nursing care of the patients along the study period through a grant from Boehringer Ingelheim do Brasil; MGM performed nursing care of the patients along the study period through a grant from Boehringer Ingelheim do Brasil; DC received consulting fee from Bayer, Daiichi-Sankyo, Janssen, and received research grant from Stago; FAMC received honoraria for lectures from Bayer; PC has participation as principal investigator in clinical trials for Novo Nordisk and participation in advisory boards for Ach, Biogen, EMS, Nutricia, Roche, and developed material for continuous medical education and participation as speaker in symposia sponsored by Ach, Nutricia, Libbs, Roche, Sandoz, Torrent, and Zodiac. ACR, RN, MCE-R, CAMT, IRMER, DMG, FAB-J, AFP, and SMB have no disclosures.
